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Abstract
Background and Objective: Chronic inflammation is the typical sign of  gastritis that may shift into gastric cancer. IL-
17A and IL-17F as a novel inflammatory cytokines subset of  CD4+Th play the main role in inflammation. A key cytokine 
receptor in the inflammatory IL-17/IL-23 axis, the interleukin 23 receptor (IL23R), may be related to gastritis. We evaluated 
the correspondence between IL-17A G197A, IL-17F A7488G and IL23R+2199 A/C polymorphisms with TGF-β1, IL-6, 
IL-17, IL-21 and IL-23 mucosal mRNAs expression in uninfected H. Pylori (HP) chronic gastritis patients.
Materials and Methods: Total RNA and genomic DNA were separated from gastric biopsies of  44 patients with gastritis. 
Subsequently, mucosal mRNAs expression of  TGF-β1, IL-6, IL-17, IL-21 and IL-23 were assessed by real-time PCR. To 
polymorphisms determination of  IL-17A G197A, IL-17F A7488G and IL-23R +2199A/C the PCR-RFLP was used in 
gastric biopsies.
Results: Results point that IL-17A G197A, IL-17F A7488G and IL23R +2199A/C polymorphisms did not influence the 
mucosal expression of  TGF-β1, IL-6, IL-17 and IL-21 (p> 0.05). In an opposite result, we don’t find a correspondence 
between IL-17A G197A, IL-17F A7488G polymorphisms and mucosal expression of  IL-23 (p> 0.05). In a contrary, we 
found a correlation between IL23R +2199A/C polymorphism and mucosal expression of  IL-23 in patients with chronic 
gastritis (p< 0.05).
Conclusion: These findings propose that IL23R +2199A/C polymorphism may change the mucosal expression of  IL-23 
pattern in patients with gastritis disease in the absence of  HP, but to support the conclusion, more research may be required.
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Introduction
There are a connection between inflammation in gas-
tric mucosa, gastritis 1, 2 and infiltration immune cells, 
such as  mononuclear and polynuclear cells, in the gas-
tric mucosa that keeps up and expands the local in-
flammation 3, 4. Polymorphisms in a few cytokines and 
their receptors are thought to play a part in outcome of  
gastric inflammation2, 5-7. It is proposed  that polymor-
phisms of  inflammatory cytokine, causes inflammatory 
response of  gastric mucosa, like TNF-α, IL-1β, IL-8, 
IL-10 and IL-17A, have been related to an increased 
risk of  gastric cancer and peptic ulcer in the digestive 
system 8-10. T helper 17 cells (Th17) are IL-17 producing 
Th cells11,12. Recent studies revealed an inflammatory 
pathway of  IL-23/IL-17 axis play the pivotal role in in-
flammatory and autoimmune diseases such as long-last-
ing autoimmune disease, inflammation of  the kidney 
and intestinal inflammation 13. The IL-23 is responsible 
for stimulating of  Th17 in this inflammatory pathway13. 
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IL-23R play a significant role in the starting, keeping 
up and accelerating in the signaling of  IL-23/IL-17 in-
flammatory axis 14. A strong association was found by 
Duerr et al  between Crohn’s disease (CD)  and poly-
morphisms in the IL23R gene in 2006  15. The result of  
previous studies shows the functional SNP of  IL23R 
+2199A/C (rs10889677) located in the 3-untranslated 
region (UTR) was repeatedly proved to be associated 
with diverse autoimmune and inflammatory diseases. 
However, similar studies have different outcomes in 
various diseases 15-17. On the other hand, IL-17F has 
the most homology with IL-17A, and like IL-17A, trig-
gers a wide range of  cytokines and adhesion molecules 
by different types of  human cells 18 However, IL-17A 
has more activities than IL-17F 19. Various studies on 
colorectal, prostate, breast and gastric tumor cells show 
an increased expression of  IL-17A 20, 21. Polymorphisms 
of  IL-17A G197A (rs2275913) and IL-17F A7488G 
(rs763780) have recently been identified to be associat-
ed with the susceptibility to ulcerative colitis and rheu-
matoid arthritis respectively 22, 23. Genetic variations in 
inflammation-related genes, particularly cytokines and 
their receptors are thought to play a role in the outcome 
of  infection and the development of  gastritis. Consid-
ering that chronic gastritis and genetic predisposition 
are important parts of  a complex interaction to initiate 
gastric carcinogenesis, and these polymorphisms have 
been associated with gastric cancer in these patients. As 
a result, our study suggests that these polymorphisms 
may alter the mucosal cytokine IL-23/IL-17 axis pat-
tern by regulating TGF-β1, IL-6, IL-17, IL-21 and IL-
23 mucosal mRNAs produced and, probably, the con-
sequent release of  these cytokines. Ultimately, these 
changes can lead to development of  severe histological 
changes in the gastric mucosa patients with gastritis 
without HP role (Fig.1).
 
Fig.1. Schematic figure showing possible mechanism of polymorphism in  IL-17A, IL-17F and  
IL-23 receptor that may affect some of the  IL-17/IL-23 axis. IL-17/IL-23 axis is the key inflammatory  
pathway including main cytokines as TGF-β, IL-6, IL-17, IL-21 and IL-23. Polymorphisms in IL-17A,  
IL-17F and IL-23R were shown as pivotal site of IL-17/IL-23 that may affect expression of TGF-β, IL-6,  
IL-17, IL-21 and IL-23 separately. 
Subjects and methods
Among patients undergoing upper gastrointestinal 
endoscopy a total of  44 gastritis patients without HP 
infection, 20 men (45.5 percent) and 24 women (54.5 
percent), were selected and histological examination of  
biopsies taken from the corpus. The process of  obtain-
ing data, including demographic and clinical data was 
done through interviews using a standard clinical pro 
forma. Exclusion criteria for the study was include the 
history of  gastric neoplasm, surgery, Enterohepatic-re-
lated problems, and previous treatment with non-ste-
roidal anti-inflammatory drugs (NSAIDs), proton 
pump inhibitors, antibiotics, or bismuth salts. Informed 
consents for participation were signed with full knowl-
edge by all the study patients. The demographic data of  
all subjects were demonstrated in Table 1. There was no 
significant difference through the subjects with respect 
to the age and gender distribution, so that patients don't 
have the same age range.
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Ethic approval
The study was approved by the human research eth-
ics committee at the Shahrekord University of  Medical 
Sciences and informed consent was obtained from each 
volunteer before participation.
Histological examination
Gastric biopsy specimens were embedded in 10 % buff-
ered formalin to preparation of  paraffin block, then 
stained with Hematoxylin and Eosin (H&E) to examine 
gastritis. The histological examination of  gastritis was 
blindly performed according to the Updated Sydney 
System.
DNA isolation
Genomic DNA was purified from biopsies taken the 
corpus using Biospin Tissue Genomic DNA Extrac-
tion Kit (Bio Flux, Japan). All extracted DNA was re-
suspended in Ultra-Pure RNase/DNase-Free Distilled 
water.
 
Genotype Determination for IL-17A G197A, IL-17F 
A7488G and IL23R +2199A/C polymorphisms
Genotyping analysis of  IL-17A, IL-17F and IL23R 
genotyping were performed by polymerase chain reac-
tion restriction fragment length polymorphism (PCR-
RFLP) as reported by Wu et al and Chen B et al 24, 25. 
The PCR cycles was performed in a total volume of  
25 µL mixture containing: 100 ng genomic DNA, 1.0 
µM of  each primer, 200 µM of  each dNTP, 2.0 mM 
of  MgCl2 and 1.0 U Taq DNA polymerase and 10X 
Taq buffer (Fermentas) using the BiometraTgradient 96 
(Biometra, Germany). PCR conditions were as follows: 
Denaturation at 96 °C for 6 min, followed by 34 cycles 
of  95 °C for 60 s, 65 °C for 60 s, and 72 °C for 52 s. A 
final extension was carried out at 72 °C for 6 min for 
IL-17A; denaturation at 95 °C for 6 min, followed by 34 
cycles of  95 °C for 63 s, 65 °C for 56 s, and 72 °C for 60 
s. A final extension was carried out at 72 °C for 6 min 
for IL-17F; denaturation at 95 °C for 5 min, followed 
by 38 cycles of  95 °C for 30 s, 60 °C for 45 s, and 72 °C 
for 60 s. A final extension was carried out at 72 °C for 
11 min for IL23R then products cooling down to 4 °C. 
The PCR products were digested by restriction endo-
nuclease XagI (Fermentas) for IL-17A G197A, NlaIII 
(Fermentas) for IL-17F A7488G and MnLI (Fermentas) 
for IL23R +2199A/C according to the manufacturer’s 
instructions, at 37°C overnight and then separated by 
10% polyacrylamide gel electrophoresis. Gene analysis 
was performed on gel stained with Ethidium Bromide 
(EtBr). PCR products were shown to be digested into 
three types of  fragments. To confirm the genotyping 
results, selected PCR samples in patient, including sam-
ples of  each genotype were re-genotyped by other lab-
oratory personnel. No significant difference was found 
after genotyping the randomly selected samples (Fig.2).
Table 1. Demographic data of study subjects 
Variable Frequency Age Mean ± SD (year) 
















37.58 ± 17.27 
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Quantitative analysis for TGF-β1, IL-6, IL-17, IL-
21 and IL-23 in the gastric mucosa using real-time 
PCR
In the current study, we selected biopsies from all 44 
biopsies from under study population, patients with ei-
ther G197A, A7488G and +2199A/C polymorphisms 
in IL-17A, IL-17F and IL23R matched by sex, age and 
pathology. Total RNA was isolated from whole gastric 
biopsy specimens using total RNA extraction biozol 
(bioflux, Japan). An aliquot containing 0.2 μg of  total 
RNA was used for the reverse transcription reaction, 
which was conducted using the superscript first-strand 
cDNA synthesis system (Fermentas, Finland) accord-
ing to the manufacturer’s instructions. The sequences 
of  oligonucleotide primer and probe are specified in 
Table 2. The relative amount of  TGF-β1, IL-6, IL-17, 
IL-21and IL-23mRNAs levels were performed using a 
Rotor-Gene 3000 (Corbett). Real-time-PCR reactions 
were conducted in a total volume of  25 μl containing 
3 μl of  synthesized cDNA solution, 12.5 μl of  2x Ro-
tor-Gene Probe PCR Master Mix (Qiagen, Germany), 
500 nM of  each primer and 250 nM of  the TaqMan 
probe. Amplification program included a pre warming 
step (10 min at 94 ºC), denaturation step (94 °C for 
15 s) and an annealing/extension step (60 °C for 60 s). 
Relative quantification of  cytokine to β-actin (cytokine 
mRNA/β-actin mRNA) was determined using the 2-ΔCт 
method 26.
Fig. 2.  PCR-RFLP polyacrylamide gel electrophoresis of the IL-17A G197A and IL-17F A7488G and IL23R +2199A/C (rs10889677) 
polymorphism indicating: (A) IL-17A G197A, No. 1, 2, 5, 9 (AA = 102 bp) 4, 7, 8 (AC = 102, 68, 34 bp) 3, 6 (GG = 68, 34 bp) genotypes 
and (B) IL-17F A7488G, No. 2, 4, 6 (AA = 80, 63 bp) 3, 7 (GA = 143, 80, 63 bp) 1, 5 (GG = 143 bp) genotypes and  (C) IL23R +21199A/C 
(re10889677), No 1 (CC = 154, 61 bp), 2, 3, 4, 5 (AC = 215, 154, 61 bp), 6, 7 (AA = 215 bp) genotypes 
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Table 2.  Primer and probe sequences employed in this study 
Gene                    Primer and probe sequence 
  
β-actin                        Forward 5-AGCCTCGCCTTTGCCGA-
3                                                                           
                                  Reverse 5-CTGGTGCCTGGGGCG-3 
                                  Probe  FAM-CCGCCGCCCGTCCACACCCGCC-TAMRA 
TGF-β1                      Forward 5-CAGCAACAATTCCTGGCGATA-3 
                                    Reverse 5-AAGGCGAAAGCCCTCAATTT-3 
                                    Probe  FAM-CTGCTGGCACCCAGCGACTCG-TAMRA 
IL-6                           Forward 5-GGTACATCCTCGACGGCATCT-3 
                                   Reverse 5-GTGCCTCTTTGCTGCTTTCAC-3 
                                   Probe  FAM-TGTTACTCTTGTTACATGTCTCCTTTCTCAGGGCT-TAMRA 
IL-17                         Forward 5-AATCTCCACCGCAATGAGGA-3 
                                   Reverse 5-ACGTTCCCATCAGCGTTGA-3 
                                   Probe  FAM-CGGCACTTTGCCTCCCAGATCACA-TAMRA 
IL-21                         Forward 5-TGTGAATGACTTGGTCCCTGAA-3 
                                   Reverse 5-AACAGGAAAAAGCTGACCACTCA-3 
                                   Probe  FAM-TCTGCCAGCTCCAGAAGATGTAGAGACAAAC-TAMRA 
IL-23                         Forward 5-TCAGTGCCAGCAGCTTTCAC-3 
                                   Reverse 5-TCTCTTAGATCCATGTGTCCCAC-3 




Data were analyzed using SPSS 16.0 (SPSS Inc, Chica-
go, IL). Cytokine expression is presented as means and 
differences between patients with gastritis were analyz-
ed using the Mann-Whitney test and for comparison of  
more than two groups Kruskal-Wallis tests were used. 
P-values of  less than 0.05 were considered significant.
Results
Expression of  mucosal mRNAs TGF-β1, IL-6, IL-
17, IL-21 and IL-23 in biopsies of  gastritis patients 
with SNPs in IL-17A G197A gene
TGF-β1, IL-6, IL-17, IL-21and IL-23 mRNAs were 
detectable in all biopsies were taken from gastritis pa-
tients. Since polymorphisms in IL-17A may affect mu-
cosal cytokine IL-23/IL-17 axis function, we studied 
the expression of  inflammation related cytokines in 
the gastric mucosa of  patients with polymorphisms IL-
17A (A/A, A/G and G/G). As shown in Fig. 3, the 
expression of  TGF-β1 (p=0.059), IL-6 (p=0.834), IL-
17(p=0.501), IL-21(p=0.999) and IL-23 (p=0.330) were 
not significant higher in patients with SNPs in IL-17A 
gene than in wild type cases.
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Figure 3.  Expression of cytokines in biopsies gastritis patients with SNPs in IL-17A G197Agene. Reverse transcription 
and quantitative PCR were performed to estimate the relative expression levels of each cytokine. Expression of TGF-β 
IL-6 (B), IL-17 (C), IL-21 (D) and IL-23 (E)were normalized with expression values of human β-actin. Difference in       
mRNA expression between patients with SNPs in IL-17A G197Awere not significant in gastritis patients. 0.05 > p was  
                        considered statistically significant using the Mann–Whitney test. 
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and quantitative PCR were performed to stimate the r lative expr ssion levels of each cytokin . Expression of TGF-β 
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Expression of  mucosal mRNAs TGF-β1, IL-6, IL-
17, IL-21and IL-23 in biopsies of  gastritis patients 
with SNPs in IL-17F A7488G gene
TGF-β1, IL-6, IL-17, IL-21and IL-23 mRNAs were 
detectable in all biopsies were taken from gastritis pa-
tients. Since polymorphisms in IL-17A may affect mu-
cosal cytokine IL-23/IL-17 axis function, we studied 
the expression of  inflammation related cytokines in the 
gastric mucosa of  patients with polymorphisms IL-17A 
(A/A, A/G and G/G). As shown in Fig. 4, the expres-
sion of  TGF-β1 (p=0. 059), IL-6 (p=0. 834), IL-17 
(p=0. 501), IL-21 (p=0. 999) and IL-23 (p=0. 330) were 
not significantly higher in patients with SNPs in IL-17A 
gene than in wild type cases.
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  Figure 4. Expression of cytokines in biopsies gastritis patients with SNPs in IL-17F A7488Ggene. Reverse transcription  
and quantitative PCR were performed to estimate the relative expression levels of each cytokine. Expression of TGF-β1 
(A), IL-6 (B), IL-17 (C), IL-21 (D) and IL-23 (E)were normalized with expression values of human β-actin. Difference in  
mRNA expression between patients with SNPs in IL-17F A7488Gwere not significant in gastritis patients. 0.05 > p was  
considered statistically significant using the Mann–Whitney test. 
  
Expression of  mucosal mRNAs TGF-β1, IL-6, IL-
17, IL-21and IL-23 in biopsies of  gastritis patients 
with SNPs in IL23R +2199A/C gene
TGF-β1, IL-6, IL-17, IL-21 and IL-23mRNAs were 
detectable in all biopsies were taken from gastritis pa-
tients. Since polymorphisms in IL23R may affect IL-
23/IL-17 axis function, we studied the expression of  
inflammation-related cytokines in the gastric mucosa 
of  patients with polymorphisms in IL23R (A/A, A/C 
and C/C genotypes). As shown in Fig. 5, the expression 
of  TGF-β1 (p=0.483), IL-6 (p=0.422), IL-17(p=0.120) 
and IL-21(p=0.646) were not significantly higher in 
patients with SNPs in IL23R +2199A/C gene, but IL-
23 (p=0.038) was significantly higher in patients with 
SNPs in IL23R (A/A genotype (gene.
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Figure 5.  Expression of cytokines in biopsies gastritis patients with SNPs in IL23R +2199A/C gene. Reverse  
transcription and quantitative PCR were performed to estimate the relative expression levels of each cytokine.  
Expression of TGF-β1 (A), IL-6 (B), IL-17 (C), IL-21 (D) and IL-23 (E)were normalized with expression values  
of human β-actin. Difference in mRNA expression between patients with SNPs in IL23R +2199A/A was significant  
in IL23 expression but don’t observed significant between patients with other SNPs in gastritis patients. 0.05 > p was  
considered statistically significant using the Mann–Whitney test. 
Discussion
Of  the beginning, the discovery of  HP was ground 
breaking news to shift in gastroenterology research 
worldwide. The bacterial diversity and unclear associa-
tion with certain digestive problem were on the top list 
of  queries about this mysterious organism 27.
The correlation of  genetic host factors in  gastroduo-
denal diseases has been demonstrated in previous re-
ports with genes participating in the  inflammatory re-
sponse28,29. Regulation of  the immune response seems to 
be critical in determining the severity of  damage to the 
host cells 29, 30. Previously, we have shown that IL-17A 
G197A, IL-17F A7488G and IL23R +2199A/C poly-
morphisms no alter the mucosal cytokine pattern in Ira-
nian patients with HP-associated gastritis diseases31. In 
this study, we eliminate the role of  HP as a side factor, it 
may lead to sharp result in our study, then we suspect IL-
17A, IL-17F and IL23R genotypes confers an increased 
risk for development of  gastritis and the rapid progres-
sion of  gastric mucosal atrophy via affect the mucosal 
expression mRNA IL-17 and IL-23 in chronic gastritis 
stage. In the present study, we found that IL-17A and 
IL-17F genotypes were not related to the mRNA mu-
cosal expression of  IL-17 and IL-23. As a same way, we 
don’t observed relationship between IL23R genotypes 
and mucosal expression of  IL-17 in gastritis subjects. In 
the other hand, we found that A/A genotype of  IL23R 
polymorphism can increase the mucosal expression of  
mRNA in IL-23 in under study subject. These findings 
suggest that IL-17A, IL-17F and IL23R (A/C and C/C 
genotypes) polymorphisms have no effect on mucosal 
expression of  IL-17 and IL-23, but IL23R polymor-
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phism affects the mucosal expression of  IL-23 involved 
in IL-23/IL-17 axis. Recent studies have suggested that 
IL-17 plays a main role in the inflammatory response 
and finally influences the gastric diseases and regulates 
immunity response 32-34. Arisawa et al reported that IL-
17F 7488 polymorphism was related to increases in the 
gastric inflammation 35. It is well known that IL-17F can 
induce a diverse set of  pro-inflammatory cytokines and 
chemokines as well as powerful inhibitors of  gastric 
acid secretion36, 37. Xiaoqin et al suggested that IL-17F 
might promote tumor progression by facilitating tumor 
proliferation and invasion into neighboring tissues and 
lymph node and the IL-17A 197 polymorphism is asso-
ciated with increased risk of  certain subtypes of  gastric 
cancer, but not with total gastric cancer risk 24. Horvath 
et al. studies indicate that IL-23 makes a contribution 
to both Th1 and Th17 responses during the chronic 
stage of  gastritis 38. Another study indicated that poly-
morphisms of  IL23R gene were associated with gastric 
cancer in a low risk Chinese population, they found the 
IL23R +2199CC genotype significantly decreased gas-
tric cancer risk 25. Together with their previous result 
that IL-17F 7488GG genotype markedly elevated the 
risk of  gastric cancer 34. The possible explanation for 
their result is, by modifying transcription factor binding 
sites or affecting the structure of  mRNA, the IL23R 
+2199A/C polymorphism located in 3-UTR might 
lower the level of  IL-23R expression and modulate the 
function of  IL-23/IL-17 inflammatory axis, which was 
reported to get actively involved in the chronic gastritis 
step of  intestinal type of  gastric cancer formation 34. 
IL23R is an important modulator in the inflammatory 
process. Patients with precancerous lesions in young-
er age are more likely to have early stage lesions and 
may have stronger immunity to prevent against the car-
cinogenic agents 39. Therefore, the inverse association 
based on the immunity activation is easier to be imple-
mented in younger population 40. On one hand, it pro-
motes a pro-inflammatory environment by dominating 
innate and inflammatory cells which are associated with 
inflammatory correlated carcinoma according to the 
previous literature; IL-23/IL-17 axis has two different 
roles in tumorigenesis 40. By contrast, this IL-23/IL-17 
pathway might also purpose tumor immune surveillance 
of  elimination, equilibrium and escape 41. The former 
role could partially involve in the pathogenesis gastric 
cancer, while ovary cancer prone to be associated with 
the latter mechanism. However, our study suggests that 
these polymorphisms may alter the mucosal cytokine 
pattern by regulating IL-17 and IL-23 production and, 
probably the consequent release of  these cytokines, 
causes the development of  severe histological changes 
in the gastric mucosa patients with gastritis. Our results 
highlighted the role of  IL23R A/A genotype in mu-
cosal expression IL-23 in patients with gastritis without 
the role of  HP as interfering factor. We suggest same 
study in other population to more evaluate the role of  
these polymorphisms in IL-23/IL-17 pathway.
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